DK0422217T3 - Human, rekombinant, placental ribonucleaseinhibitor og fremgangsmåde til produktion - Google Patents

Human, rekombinant, placental ribonucleaseinhibitor og fremgangsmåde til produktion

Info

Publication number
DK0422217T3
DK0422217T3 DK90908084.8T DK90908084T DK0422217T3 DK 0422217 T3 DK0422217 T3 DK 0422217T3 DK 90908084 T DK90908084 T DK 90908084T DK 0422217 T3 DK0422217 T3 DK 0422217T3
Authority
DK
Denmark
Prior art keywords
ribonuclease inhibitor
placental ribonuclease
human placental
human
recombinant
Prior art date
Application number
DK90908084.8T
Other languages
Danish (da)
English (en)
Inventor
Martin Kendall Lewis
John William Shultz
Original Assignee
Promega Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promega Corp filed Critical Promega Corp
Application granted granted Critical
Publication of DK0422217T3 publication Critical patent/DK0422217T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90908084.8T 1989-04-24 1990-04-18 Human, rekombinant, placental ribonucleaseinhibitor og fremgangsmåde til produktion DK0422217T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34236289A 1989-04-24 1989-04-24

Publications (1)

Publication Number Publication Date
DK0422217T3 true DK0422217T3 (da) 1998-03-02

Family

ID=23341508

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90908084.8T DK0422217T3 (da) 1989-04-24 1990-04-18 Human, rekombinant, placental ribonucleaseinhibitor og fremgangsmåde til produktion

Country Status (8)

Country Link
EP (1) EP0422217B1 (ja)
JP (2) JP3009458B2 (ja)
AT (1) ATE162853T1 (ja)
AU (1) AU646803B2 (ja)
DE (1) DE69031996T2 (ja)
DK (1) DK0422217T3 (ja)
ES (1) ES2111537T3 (ja)
WO (1) WO1990012881A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3884853T2 (de) * 1987-04-14 1994-02-03 Harvard College Angiogenininhibitoren.
US7560248B1 (en) 1999-01-20 2009-07-14 Wisconsin Alumni Research Foundation Oxidation-resistant ribonuclease inhibitor
AU5927900A (en) * 1999-07-13 2001-01-30 Zymogenetics Inc. Alpha protein - 27
DE102005015005A1 (de) * 2005-04-01 2006-10-05 Qiagen Gmbh Verfahren zur Behandlung einer Biomoleküle enthaltenden Probe
GB201101794D0 (en) * 2011-02-02 2011-03-16 Fermentas Uab Protein production
PL436077A1 (pl) * 2020-11-25 2022-05-30 Blirt Spółka Akcyjna Liofilizowany i gotowy do liofilizacji rekombinowany ludzki inhibitor RNaz

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3884853T2 (de) * 1987-04-14 1994-02-03 Harvard College Angiogenininhibitoren.

Also Published As

Publication number Publication date
AU646803B2 (en) 1994-03-10
JP3366596B2 (ja) 2003-01-14
JP2000078992A (ja) 2000-03-21
ATE162853T1 (de) 1998-02-15
EP0422217A1 (en) 1991-04-17
JP3009458B2 (ja) 2000-02-14
DE69031996D1 (de) 1998-03-05
WO1990012881A1 (en) 1990-11-01
JPH03505677A (ja) 1991-12-12
DE69031996T2 (de) 1998-06-10
ES2111537T3 (es) 1998-03-16
EP0422217A4 (en) 1992-08-19
EP0422217B1 (en) 1998-01-28
AU5537790A (en) 1990-11-16

Similar Documents

Publication Publication Date Title
NO179253C (no) Rekombinant DNA-sekvens som koder for humant proapolipoprotein A-I, ekspresjonsvektorer, cellekulturer samt fremgangsmåte for fremstilling av proteinet
EP0722461A4 (en) EXPRESSION OF FUSION POLYPEPTIDES TRANSPORTED OUT OF CYTOPLASM WITHOUT HEAD SEQUENCE
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
DE60033138D1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
ATE294871T1 (de) Nicht-toxisches, nicht-toxigenes, nicht- pathogenes fusarium expressionssystem und darin zu verwendende promotoren und terminatoren
EP0048970A3 (en) Polypeptides, process for their microbial production, intermediates therefor and compositions containing them
DE69840230D1 (de) Polypeptide mit prolyldipeptidylaminopeptidase-aktivität und dafür kodierende nukleinsäuren
IL175021A0 (en) Chromatin insulator, its preparation and use in protein expression
DE69839553D1 (de) Verfahren zur herstellung von proteinen
DK0804558T3 (da) Tripeptidylaminopeptidase
DK0422217T3 (da) Human, rekombinant, placental ribonucleaseinhibitor og fremgangsmåde til produktion
DE69634757D1 (de) Vektor zur expression von n-terminal verlängerten proteinen in hefezellen
KR900702010A (ko) 루시페라아제, 그것을 코우드 하는 유전자 및 루시페라아제의 생산방법
DE69333304D1 (de) Erhöhte produktion von sekretierten proteinen durch rekombinante eukaryotische zellen
ATE317896T1 (de) Polypeptide mit glucanotransferase aktivität und dafür kodierende nukleinsäuren
EP0183272A3 (en) Vector capable of efficient gene expression and utilization of such vector
MX9802646A (es) Citocromo c y su gen.
FI934079A (fi) Menetelmä fuusioproteiinin valmistamiseksi
DK0592574T3 (da) Fremgangsmåde til fremstilling af rekombinante proteiner og værtsceller anvendt derved
DK0663955T3 (da) Nucleinsyre, som koder for en alfa-acetolactat-decarboxylase, og anvendelser deraf
WO2002081708A1 (fr) Procede de production de prothease thiol d3